Madrid, Spain

Angela Basilio

This inventor holds 6 USPTO granted patents, plus 2 CIPO patents and 2 EPO patents. Top assignees: Merck + Co., Inc., Merck Sharp & Dohme De Espana Sa, Merck Sharp + Dohme Corp.. Active years: 1996-2010.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Angela Basilio. Retrieved from https://idiyas.com/inventor/angela-basilio

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0



Average Co-Inventor Count = 9.3

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 1996-2010

Loading Chart...
Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: Angela Basilio: Innovating Antibiotic Compounds in Madrid

Introduction:

Angela Basilio, a prominent inventor based in Madrid, Spain, has made significant contributions to the field of pharmaceuticals through her groundbreaking innovations.

Latest Patents:

Basilio's latest patents include the development of two antibiotic compounds through the fermentation of a nutrient medium with a eubacterium sp. These compounds exhibit a novel antibacterial activity and have a unique structural formula.

Career Highlights:

With an impressive portfolio of 6 patents to her name, Basilio has demonstrated her expertise in the pharmaceutical industry. She has been at the forefront of developing novel drugs that address antibiotic resistance and combat infectious diseases.

Collaborations:

Throughout her career, Basilio has collaborated with esteemed companies such as Merck & Company, Inc. and Merck Sharp & Dohme Corporation. Her innovative work alongside coworkers like Fernando Pelaez and Francisca Vicente has led to the successful development of new pharmacological agents.

Conclusion:

Angela Basilio's dedication to innovation and her pioneering work in the field of antibiotic compounds have solidified her reputation as a respected inventor in Madrid. Her contributions continue to positively impact the pharmaceutical industry and pave the way for future advancements in healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…